During the past decade, Providence Health Partners-Center for Clinical Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 13 clinical trials were completed, i.e. on average, 216.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Health Partners-Center for Clinical Research" #1 sponsor was "Mannkind Corporation" with 4 trials, followed by "AstraZeneca" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored and "Urovant Sciences GmbH" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Health Partners-Center for Clinical Research" #1 collaborator was "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator, "BARC Global Central Laboratory" with 1 trials as a collaborator, "Bilcare Global Clinical Supplies" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Providence Health Partners-Center for Clinical Research" are "Type 2 Diabetes" (3 trials), "Diabetes Mellitus, Type 2" (2 trials), "Overactive Bladder" (2 trials), "Type 1 Diabetes" (2 trials) and "Aneuploidy" (1 trials). Many other conditions were trialed in "Providence Health Partners-Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Providence Health Partners-Center for Clinical Research" are "Drug" (22 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Dapagliflozin" (2 trials), "Technosphere Insulin" (2 trials), "Tolterodine Tartrate ER" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Providence Health Partners-Center for Clinical Research" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Providence Health Partners-Center for Clinical Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Providence Health Partners-Center for Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Providence Health Partners-Center for Clinical Research, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".